R
Avita Medical D
D
RCEL
5.16000
USD
-0.10
(-1.90%)
مغلق
حجم التداول
5,736
الربح لكل سهم
-0
العائد الربحي
-
P/E
-2
حجم السوق
136,402,835
الأخبار المقالات
العنوان: Avita Medical
القطاع: Healthcare
الصناعة: Medical Devices
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.